CEL-SCI Corp
Photos
CEL-SCI Corporation, based in Elkridge, MD, is a biotechnology company dedicated to advancing cancer treatment through innovative immunotherapy solutions. Their flagship product, Multikine, aims to enhance patients' immune responses before the onset of traditional cancer therapies, such as surgery, radiation, and chemotherapy.
The company has made significant strides in clinical research, highlighted by the largest Phase III trial in head and neck cancer involving 928 patients. CEL-SCI's mission is to improve treatment outcomes by leveraging the body's natural defense mechanisms, with a vision to fundamentally change cancer therapy.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.